دورية أكاديمية
أعرض في EDS

Descriptive epidemiological study of rare, less common and common cancers in Western Australia.

التفاصيل البيبلوغرافية
العنوان: Descriptive epidemiological study of rare, less common and common cancers in Western Australia.
المؤلفون: Bilkey GA; Patient Safety and Clinical Quality, Clinical Excellence Division, Department of Health, East Perth, Western Australia, 6004, Australia. Gemma.Bilkey@health.wa.gov.au.; Office of Population Health Genomics, Public and Aboriginal Health Division, Department of Health, East Perth, Western Australia, 6004, Australia. Gemma.Bilkey@health.wa.gov.au., Trevithick RW; Western Australian Cancer Registry, Clinical Excellence Division, Department of Health, East Perth, Western Australia, 6004, Australia., Coles EP; Office of Population Health Genomics, Public and Aboriginal Health Division, Department of Health, East Perth, Western Australia, 6004, Australia., Girschik J; Epidemiology Branch, Public and Aboriginal Health Division, Department of Health, East Perth, Western Australia, 6004, Australia., Nowak KJ; Office of Population Health Genomics, Public and Aboriginal Health Division, Department of Health, East Perth, Western Australia, 6004, Australia.
المصدر: BMC cancer [BMC Cancer] 2021 Jul 08; Vol. 21 (1), pp. 779. Date of Electronic Publication: 2021 Jul 08.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Neoplasms/*epidemiology , Rare Diseases/*epidemiology, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Neoplasms/mortality ; Survival Analysis ; Western Australia ; Young Adult
مستخلص: Background: There are no epidemiological studies describing rare cancers in Western Australia (WA). We aimed to fill this gap by estimating the incidence and five-year survival of rare, less common and common cancers in WA, based on definitions for rarity used by the Australian Institute of Health and Welfare and cancer groupings from the project on Surveillance of Rare Cancers in Europe (RARECARE). This research will enable policy- and decision-makers to better understand the size and nature of the public health problem presented by rare cancers in WA. It is anticipated that this study will inform improved health service design and delivery for all WA cancer patients, but particularly those with rare and less common cancers.
Methods: We estimated incidence and five-year survival rates of rare, less common and common cancers in WA using data sourced from the WA Cancer Registry for the 2013-2017 period. Cancers were defined as rare (< 6), less common (6-12), or common (> 12) based on their crude incidence rate per 100,000 people per year.
Results: Rare cancers make up 21.5% of all cancer diagnoses in WA, with a significantly poorer five-year survival of 58.2% (95% confidence interval (CI) 57.3-59.1%), compared to patients diagnosed with a common cancer, whose five-year survival was 87.8% (95% CI 87.3-88.3%). Survival for less common cancers was significantly poorer than both rare and common cancers, at 48.1% (95% CI 47.3-49.0%). Together, rare and less common cancers represent 48.4% of all cancer diagnoses in WA.
Conclusions: While rare cancers are individually scarce, collectively over one in five cancer patients in WA are diagnosed with a rare cancer. These patients experience significantly worse prognoses compared to patients with common cancers.
References: Ecancermedicalscience. 2013 May 21;7:ed20. (PMID: 24883089)
Tumori. 2017 Jan 21;103(1):22-32. (PMID: 27716878)
Cancer Epidemiol. 2018 Jun;54:95-100. (PMID: 29684802)
BMJ. 2003 Jul 5;327(7405):47-9. (PMID: 12842959)
Eur J Cancer. 2011 Nov;47(17):2493-511. (PMID: 22033323)
Eur J Surg Oncol. 2019 Jan;45(1):22-30. (PMID: 29526369)
Lancet Oncol. 2016 Feb;17(2):e52-e61. (PMID: 26868354)
Eur J Surg Oncol. 2019 Jan;45(1):3-11. (PMID: 29032924)
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. (PMID: 26951748)
Eur J Cancer Prev. 2018 Jul;27(4):384-390. (PMID: 25969132)
Eur J Surg Oncol. 2019 Jan;45(1):16-18. (PMID: 29685758)
Cell Chem Biol. 2017 Sep 21;24(9):1075-1091. (PMID: 28938087)
Eur J Surg Oncol. 2015 Sep;41(9):1115-7. (PMID: 25936223)
Indian J Med Res. 2017 Jan;145(1):17-27. (PMID: 28574010)
Eur J Cancer. 2009 Mar;45(5):747-55. (PMID: 19117750)
Cancer Epidemiol. 2020 Aug;67:101702. (PMID: 32535408)
Aust J Rural Health. 2015 Feb;23(1):32-9. (PMID: 25689381)
CA Cancer J Clin. 2017 Jul 8;67(4):261-272. (PMID: 28542893)
Genet Med. 2017 May;19(5):546-552. (PMID: 27657686)
Rare Tumors. 2012 Apr 12;4(2):e24. (PMID: 22826781)
Health Place. 2018 Sep;53:219-227. (PMID: 30193178)
Lancet Oncol. 2006 Feb;7(2):132-40. (PMID: 16455477)
Cancer Med. 2020 Aug;9(15):5632-5642. (PMID: 32436657)
Cancer Epidemiol. 2014 Oct;38(5):490-5. (PMID: 25155209)
ESMO Open. 2020 Mar;5(2):. (PMID: 32220947)
Natl Cancer Inst Monogr. 1961 Sep;6:101-21. (PMID: 13889176)
Public Health Rep. 2010 Jan-Feb;125(1):28-43. (PMID: 20402194)
Front Public Health. 2019 Mar 07;7:42. (PMID: 30899755)
فهرسة مساهمة: Keywords: Epidemiology; Incidence; Less common cancer; RARECARE; Rare cancer; Survival; Western Australia
تواريخ الأحداث: Date Created: 20210708 Date Completed: 20211102 Latest Revision: 20211102
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8265087
DOI: 10.1186/s12885-021-08501-4
PMID: 34233636
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2407
DOI:10.1186/s12885-021-08501-4